Skip to main content
Vistin Pharma logo

Vistin Pharma — Investor Relations & Filings

Ticker · VISTN ISIN · NO0010734122 LEI · 5967007LIEEXZXFQY092 OL Manufacturing
Open in API
Filings indexed 519 across all filing types
Latest filing 2021-02-19 Interim / Quarterly Rep…
Country NO Norway
Listing OL VISTN

About Vistin Pharma

https://www.vistin.com/

Vistin Pharma is a pharmaceutical company specializing in the production of Metformin Hydrochloride, an Active Pharmaceutical Ingredient (API). The company operates as a pure-play, global supplier, providing high-quality Metformin to pharmaceutical companies worldwide. In addition to the standard API, Vistin Pharma offers specialized grades such as Direct Compressible (DC) Metformin. With over 50 years of experience, the company emphasizes sustainable manufacturing from its dedicated European production facility.

Recent filings

Filing Released Lang Actions
Vistin Pharma ASA: Fourth quarter and preliminary 2020 financial results
Interim / Quarterly Report Classification · 100% confidence The document is a 'Fourth Quarter and Preliminary 2020 Results' report for Vistin Pharma ASA. It contains detailed financial statements (P&L, balance sheet, cash flow), operational updates, and management commentary for the quarterly period. It is not an announcement of a report (RPA) because it contains the full financial data itself, nor is it a full annual report (10-K) as it focuses on the fourth quarter and preliminary full-year results. Therefore, it is classified as an Interim/Quarterly Report. Q4 2020
2021-02-19 English
Vistin Pharma ASA: Fourth quarter and preliminary 2020 financial results
Earnings Release Classification · 100% confidence The document explicitly states it announces the 'Fourth quarter and preliminary 2020 financial results' and provides key financial highlights (revenue, EBITDA, net profit) for Q4 and the full year 2020. This strongly suggests an Earnings Release (ER). However, the final sentence states, 'Please find the Q4 report and presentation enclosed. The report will also be made available on www.vistin.com'. Given the short length (2495 chars) and the explicit mention that the full report is enclosed/attached, this document functions primarily as an announcement of the results and the availability of the full report, rather than the comprehensive report itself (which would typically be classified as IR or 10-K/IR if comprehensive). According to Rule 2, if a short document announces that the full report is attached, it should be classified as a Report Publication Announcement (RPA). Since it is announcing the release of the Q4 report and presentation, RPA is the most appropriate classification based on the provided rules, even though the content is earnings-focused. Q4 2020
2021-02-19 English
Vistin Pharma ASA: Invitation to Q4 2020 conference call
Call Transcript Classification · 85% confidence The document is titled 'Vistin Pharma ASA: Invitation to Q4 2020 conference call' and explicitly states that the company 'will host a conference call for all shareholders and interested parties on Friday 19(th) of February at 08:30 CET' following the release of Q4 2020 results. It provides dial-in numbers and a webcast link for this event, which includes a Q&A session. This content is characteristic of an announcement inviting participants to an earnings-related conference call, which falls under the 'Call Transcript' (CT) definition if it were the transcript itself, but since this is the *invitation* to the call, it is most closely related to the event that generates a Call Transcript. However, none of the definitions perfectly match an 'Invitation to a Conference Call'. The closest related category is 'Call Transcript' (CT), as this document directly precedes and announces the event that generates the CT. Given the options, and recognizing that this is an announcement about a call where management will discuss results (similar to an earnings call), CT is the most contextually relevant choice, although RPA or RNS could also be argued if it were purely a procedural announcement. Since it details the Q&A structure and access points for a results discussion, CT is prioritized over a generic RPA/RNS.
2021-02-12 English
Vistin Pharma ASA: Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document text explicitly states 'Mandatory notification of trade' and details a purchase of shares by a 'primary insider' (Commercial Director). This transaction involves an executive buying company stock, which directly corresponds to the definition of Director's Dealing (insider trades). The appropriate code is DIRS.
2021-01-05 English
Finansiell kalender
Report Publication Announcement Classification · 99% confidence The document is titled "Finansiell kalender" (Financial Calendar) and lists scheduled dates for various corporate events for Vistin Pharma ASA, including the release of the Annual Report ("Årsrapport"), Half-Year Report ("Halvårsrapport"), Quarterly Reports ("Kvartalsrapport"), and the Annual General Meeting ("Ordinær generalforsamling"). This document is an announcement about future reporting dates, not the reports themselves. Since there is no specific category for a 'Financial Calendar', and it is a general announcement regarding corporate events and reporting schedules, the most appropriate fallback category is Regulatory Filings (RNS), as it is a mandatory disclosure of the company's schedule.
2020-12-15 Norwegian
Financial calendar
Report Publication Announcement Classification · 99% confidence The document is titled 'Financial calendar' and lists future dates for various corporate events, including 'Quarterly Report', 'Half-yearly Report', 'Annual Report', and 'Annual General Meeting'. It is not the report itself, but an announcement detailing the schedule for future report publications and meetings. Since it announces the publication schedule rather than containing the detailed content of any specific report, it fits best under Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports. The document length is very short (489 chars), supporting the RPA classification over classifying it as the actual report (like 10-K or IR).
2020-12-15 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.